Terms: = Germ cell tumor AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Clinical Outcome
11 results:
1. Expression of the cancer stem cell marker oct4 is associated with worse prognosis and survival in cutaneous melanoma.
Silva CTX; Saddi VA; Silva KSFE; Sugita DM; Guillo LA
Melanoma Res; 2021 Oct; 31(5):439-448. PubMed ID: 34433195
[TBL] [Abstract] [Full Text] [Related]
2. MYC transcription activation mediated by oct4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastoma.
Wei SJ; Nguyen TH; Yang IH; Mook DG; Makena MR; Verlekar D; Hindle A; Martinez GM; Yang S; Shimada H; Reynolds CP; Kang MH
Cell Death Dis; 2020 May; 11(5):368. PubMed ID: 32409685
[TBL] [Abstract] [Full Text] [Related]
3. Primary yolk sac tumour of the prostate mimicking small round blue cell tumour.
Gui H; Kolster RA; Palmer MB; Brooks JS; Zhang M; Husson MA
Curr Oncol; 2019 Oct; 26(5):e707. PubMed ID: 31708666
[TBL] [Abstract] [Full Text] [Related]
4. High oct4A levels drive tumorigenicity and metastatic potential of medulloblastoma cells.
da Silva PBG; Teixeira Dos Santos MC; Rodini CO; Kaid C; Pereira MCL; Furukawa G; da Cruz DSG; Goldfeder MB; Rocha CRR; Rosenberg C; Okamoto OK
Oncotarget; 2017 Mar; 8(12):19192-19204. PubMed ID: 28186969
[TBL] [Abstract] [Full Text] [Related]
5. Pencil beam scanning proton therapy for pediatric intracranial ependymoma.
Ares C; Albertini F; Frei-Welte M; Bolsi A; Grotzer MA; Goitein G; Weber DC
J Neurooncol; 2016 May; 128(1):137-145. PubMed ID: 26945580
[TBL] [Abstract] [Full Text] [Related]
6. Association of cancer stem cell markers genetic variants with gallbladder cancer susceptibility, prognosis, and survival.
Yadav A; Gupta A; Rastogi N; Agrawal S; Kumar A; Kumar V; Mittal B
Tumour Biol; 2016 Feb; 37(2):1835-44. PubMed ID: 26318430
[TBL] [Abstract] [Full Text] [Related]
7. The oncofetal protein IMP3: a useful marker to predict poor clinical outcome in neuroendocrine tumors of the lung.
Del Gobbo A; Vaira V; Guerini Rocco E; Palleschi A; Bulfamante G; Ricca D; Fiori S; Bosari S; Ferrero S
J Thorac Oncol; 2014 Nov; 9(11):1656-61. PubMed ID: 25144243
[TBL] [Abstract] [Full Text] [Related]
8. A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival.
Elsir T; Edqvist PH; Carlson J; Ribom D; Bergqvist M; Ekman S; Popova SN; Alafuzoff I; Ponten F; Nistér M; Smits A
Int J Cancer; 2014 Mar; 134(5):1123-31. PubMed ID: 24037901
[TBL] [Abstract] [Full Text] [Related]
9. Expression analysis of stem cell-related genes reveal oct4 as a predictor of poor clinical outcome in medulloblastoma.
Rodini CO; Suzuki DE; Saba-Silva N; Cappellano A; de Souza JE; Cavalheiro S; Toledo SR; Okamoto OK
J Neurooncol; 2012 Jan; 106(1):71-9. PubMed ID: 21725800
[TBL] [Abstract] [Full Text] [Related]
10. Transition from 2D conventional to 3d conformal radiation therapy in patients with brain gliomas: clinical outcome (Mansoura University).
Awad IA; El-Kholi NM; El-Lithy MA; Hendawi EA; Anter AH
J Egypt Natl Canc Inst; 2009 Jun; 21(2):133-8. PubMed ID: 21057564
[TBL] [Abstract] [Full Text] [Related]
11. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.
Ben-Porath I; Thomson MW; Carey VJ; Ge R; Bell GW; Regev A; Weinberg RA
Nat Genet; 2008 May; 40(5):499-507. PubMed ID: 18443585
[TBL] [Abstract] [Full Text] [Related]
